Hepatitis B treatment methods and goals

The HBV how it treated? What is the treatment of hepatitis B? Treatment of hepatitis B has been the problem of the medical profession. We know that hepatitis B is a contagious disease, so the hepatitis B treatment has become an issue of concern, even if it will be infectious and strong hepatitis B HBeAg positive hepatitis B treatment into or. However, in the face of the divergent views of the factions, the face of overwhelming hepatitis B treatment of advertising, the face of the one deceived, hepatitis B patients confused. So, in the end the hepatitis B how to treat it? What is the treatment of hepatitis B? Hepatitis B treatment a lot of controversy, but remained generally can not be separated from the four main points.

Hepatitis B treatment is mainly reflected in the four-point: to seize the opportunity to choose the right program, long-standing, rigorous life. Here we detail for:

A good grasp of the timing of hepatitis B treatment is the key:
Most people know that they are hepatitis B, regardless of that he is not in the immune tolerance of the blind to seek hepatitis B treatment, hepatitis B antiviral, hepatoprotective, antifibrotic, looking forward to as soon as possible hepatitis B rule Well, the effect of hepatitis B treatment is often not satisfactory, but increase the burden to the family. Some even aggravate the disease, the treatment of hepatitis B is more difficult, more difficult to control the disease. Therefore, in the specific treatment of hepatitis B, hepatitis B treatment is to grasp the opportunity is the key.

The timing of hepatitis B treatment: transaminase more than twice as normal, indicating that the body's immune system is activated, began with the exclusion of hepatitis B virus reaction, while the liver cells of inflammatory injury, and this was the best time of hepatitis B antiviral therapy . The body's immune system with antiviral drugs to combat hepatitis B virus, in order to achieve a more satisfactory anti-viral effect. Unable to determine whether antiviral therapy, it is recommended to be a liver puncture, and be able to determine that there is no need to hepatitis B antiviral treatment.

The hepatitis B vaccine can prevent liver cancer

Worldwide, up to 80% of liver cancer and hepatitis B virus infection in China, 71 percent of liver cancer by the hepatitis B evolved. Professor Zhang Meihui-based research, the World Health Organization (WHO) that hepatitis B vaccine is the only vaccine that can prevent primary liver cancer and hepatitis B vaccine to prevent hepatitis B is most effective, safe and economical method.

Hepatitis B vaccine in the prevention of mother to child transmission, Professor Zhang Meihui: with HBsAg positive is the highest risk mothers and their infants is most difficult to prevent the success rate in the small-scale clinical trials in the past when everyone can reach more than 90% of the benefits of prevention, but wait until the comprehensive implementation of his achievements did not like the small-scale so well, generally statistics seem, the whole look something about Eighty - five, then the HBsAg-negative mother and negative mother gives birth to a child, he is very good, small-scale study looks close to 100% can be prevented success, the entire large-scale look close to 100 percent, but they really produce the antibody status of not so high, means they are probably there may be almost about 5% of the children does not really produce a good antibody response.

Strengthening the crowd outside the neonatal hepatitis B vaccination

In 1992, China's Ministry of Health hepatitis B vaccine into children's immunization management, and promulgated the "National Hepatitis B vaccine immunization plan"; 2002, the State Council approved the hepatitis B vaccine into children's immunization of children in large cities since the hepatitis B surface antigen (HBsAg) carrier rate is significantly reduced. HBsAg carriers to reduce the number of 20 million. However, the whole of hepatitis B surface antigen carrier rate has not decreased significantly, particularly relative to the World Health Organization on the global hepatitis B control goal is still a considerable gap. Ministry of Health in 2005 hepatitis B as AIDS, tuberculosis, schistosomiasis focus on control of infectious diseases. Proposed on the basis of further improve neonatal immunization in people that are outside the neonatal hepatitis B vaccination strategies.